Article (Scientific journals)
Emerging therapies for ionizing radiation-associated skin field carcinogenesis.
Pierard, Gérald; Pierard, Claudine; Paquet, Philippe et al.
2009In Expert Opinion on Pharmacotherapy, 10 (5), p. 813-21
Peer Reviewed verified by ORBi
 

Files


Full Text
EMERGING THERAPIES.pdf
Publisher postprint (347.47 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Animals; Antineoplastic Agents/therapeutic use; Cryotherapy/trends; Humans; Neoplasms, Radiation-Induced/etiology/therapy; Photochemotherapy/trends; Radiation, Ionizing; Skin Neoplasms/etiology/therapy
Abstract :
[en] BACKGROUND: Radiodermatitis in its acute and chronic presentations represents a set of specific adverse effects resulting from ionizing radiations. Skin-field cancerization is another condition associated to or independent of clinically recognizable radiodermatitis. This condition leads to the risk of later occurrence of skin malignancies. METHOD: Review of the current and most pertinent peer-reviewed publications with the addition of personal perspectives. RESULT/CONCLUSION: The presence of field cancerization encompasses subclinical changes, precursors of malignant alterations, as well as single or multiple primary neoplasms and local neoplastic recurrences. These tumours commonly require repeated treatments over time and cause significant morbidity. In general, specific tumour-directed treatments using ablative or destructive techniques require regular follow-up and screening for disclosing any further neoplasm. Another strategy corresponding to field-directed treatment targets a larger area of irradiated skin to reduce the risk of developing second neoplasms and local recurrences. Imiquimod is an immune response modifier of the imidazoquinoline class. It is the archetype drug used to control skin-field carcinogenesis. Cryotherapy, topical 5-fluorouracil, diclofenac and conventional photodynamic therapy are supposed to bring effects differing by their indications, healing rates and remission rates. The possibility of inducting a radiation recall dermatitis by some of these therapeutic modalities has not been thoroughly evaluated, and at present cannot be ruled out with confidence.
Disciplines :
Dermatology
Author, co-author :
Pierard, Gérald ;  Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Pierard, Claudine ;  Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Paquet, Philippe ;  Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Quatresooz, Pascale  ;  Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Language :
English
Title :
Emerging therapies for ionizing radiation-associated skin field carcinogenesis.
Publication date :
2009
Journal title :
Expert Opinion on Pharmacotherapy
ISSN :
1465-6566
eISSN :
1744-7666
Publisher :
Ashley Publications Ltd, London, United Kingdom
Volume :
10
Issue :
5
Pages :
813-21
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 10 November 2009

Statistics


Number of views
112 (2 by ULiège)
Number of downloads
1 (0 by ULiège)

Scopus citations®
 
10
Scopus citations®
without self-citations
7
OpenCitations
 
8

Bibliography


Similar publications



Contact ORBi